PRMT5 Enzyme Role in Histone Production Identified
Researchers discover that PRMT5 activity is essential for maintaining histone transcription and protein synthesis during S phase.
Updated on Oct. 21, 2026 in Life Sciences
Scientists have determined that the PRMT5 enzyme acts as a critical coordinator of histone homeostasis in proliferating cells. The study identifies that inhibiting PRMT5 leads to histone mRNA depletion and subsequent genomic instability.
Why it matters
Understanding how cells manage histone production is vital because PRMT5 is frequently overexpressed in cancer. This discovery sheds light on the mechanisms that link PRMT5 activity to cell growth and genetic integrity.
Using time-resolved nascent transcriptional profiling and quantitative proteomics, researchers established that PRMT5 catalyzes symmetric dimethylation of arginine residues. This methylation modification, specifically H4R3me2s, is heavily enriched at histone locus bodies.
The players
PRMT5
This enzyme catalyzes the symmetric dimethylation of arginine residues and is known to be overexpressed in various cancer types.
The details
The research shows that PRMT5-mediated methylation of histone H4 regulates the transcription process required for cell proliferation. When PRMT5 is inhibited or knocked down, it triggers a p53-independent depletion of histone mRNA, resulting in the loss of histone proteins and replication-associated nuclear abnormalities.
Timeline
The findings regarding PRMT5 histone research were published on October 21, 2026.
The Big Picture
This discovery advances the ongoing investigation into epigenetic regulators in oncology. It shifts the current understanding by confirming that PRMT5 is a central coordinator of histone homeostasis, rather than just a general transcriptional modifier.
This research provides a fundamental map of cellular replication processes that could eventually influence future cancer drug development. By defining how histone depletion causes genomic instability, scientists may eventually identify new pathways to target malignant cell growth.
The takeaway
The study underscores the necessity of PRMT5 in maintaining the delicate balance of histone proteins during the cell cycle. Researchers suggest that targeting this pathway could be a critical step in managing replication-associated nuclear abnormalities.
Further reading
For more on cellular biology, visit our Life Sciences section.
More information
Read the full results in the peer-reviewed research article.
Source note: This article includes information reported by Nature.
